TandemHeart to Reduce Infarct Size (TRIS Trial)
- Conditions
- Acute Myocardial Infarction
- Interventions
- Device: TandemHeart SystemProcedure: Percutaneous coronary intervention
- Registration Number
- NCT02164058
- Lead Sponsor
- CardiacAssist, Inc.
- Brief Summary
The purpose of this study is to determine if a device known as the TandemHeart® System (TandemHeart) can help limit heart damage and reduce serious complications after a certain type of heart attack (acute ST elevation anterior wall myocardial infarction \[STEMI\]) by evaluating the use of the TandemHeart system prior to a procedure called percutaneous coronary intervention (PCI)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description TandemHeart System + PCI Percutaneous coronary intervention TandemHeart System prior to percutaneous coronary intervention PCI Percutaneous coronary intervention Percutaneous coronary intervention TandemHeart System + PCI TandemHeart System TandemHeart System prior to percutaneous coronary intervention
- Primary Outcome Measures
Name Time Method Primary Safety 30 days post-procedure Major Adverse Cardiac or Cerebrovascular Events (MACCE):
* Death, all cause
* Stroke
* Reinfarction
* Major vascular complications
- Secondary Outcome Measures
Name Time Method